NEOPLASM PROGRESSION side effect
What is NEOPLASM PROGRESSION ?Drugs associated with NEOPLASM PROGRESSION
ACTONEL ALIMTA AVASTIN AVONEX BETASERON BEVACIZUMAB CABERGOLINE CISPLATIN CLARAVIS DOXIL ENDOXAN ERLOTINIB FLAGYL GEMCITABINE GENOTROPIN GLEEVEC GLIADEL ISOTRETINOIN NUTROPIN PRIALT PRINIVIL PROVIGIL RAPAMUNE REBIF REVLIMID SAIZEN SEROQUEL SUTENT TEMODAL THALOMID THYROGEN VECTIBIX VELCADE ZEVALIN ZIAGEN ZOMETANEOPLASM PROGRESSION : Zometa Side Effects Report #5670758-2
Health Professional from UNITED STATES reported ZOMETA problem on Mar 13, 2008. Male patient was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . ZOMETA dosage: 4 MG, UNK. Patient died.
NEOPLASM PROGRESSION : Provigil Side Effects Report #5677941-0
PROVIGIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2005. Female patient, 33 years of age, weighting 145.0 lb, was diagnosed with autonomic neuropathy and was treated with PROVIGIL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PROVIGIL dosage: 400 MG QD ORAL. During the same period patient was treated with FLORINEF, WELLBUTRIN, KERLONE. Patient recovered.
NEOPLASM PROGRESSION : Nutropin Side Effects Report #5645041-1
Physician from UNITED STATES reported NUTROPIN problem on Feb 19, 2008. Male patient, weighting 93.70 lb, was diagnosed with hypopituitarism and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . NUTROPIN dosage: 1.4 MG, QD. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
NEOPLASM PROGRESSION : Zevalin Side Effects Report #5590408-3
ZEVALIN problem was reported by a Physician from UNITED STATES on Dec 26, 2007. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, off label use, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN. Patient died.
NEOPLASM PROGRESSION : Nutropin Side Effects Report #5595063-4
Physician from UNITED STATES reported NUTROPIN problem on Jan 07, 2008. Male patient was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . NUTROPIN dosage: 1.4 MG, QD. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5633815-2
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; X21 DAYS/28 DAYS, ORAL. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5639485-1
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, COUMADIN, PENICILLIN, ACYCLOVIR, LEVOTHYROXINE, METHADONE, NORTRIPTYLINE, VITAMIN. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5641897-7
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Oct 12, 2007. Male patient, 58 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 10 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with VINCRISTINE, DOXEL, DECADRON. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5641936-3
Physician from UNITED STATES reported REVLIMID problem on Nov 26, 2007. Female patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Avastin Side Effects Report #5549021-6
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 10, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, small intestinal obstruction, . AVASTIN dosage: unknown. During the same period patient was treated with FOLINIC ACID, FLUOROURACIL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Rebif Side Effects Report #5567630-5
Consumer or non-health professional from UNITED STATES reported REBIF problem on Dec 03, 2007. Female patient, 37 years of age, weighting 204.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, procedural pain, . REBIF dosage: unknown. During the same period patient was treated with SYNTHROID, NEXIUM. Patient recovered.
NEOPLASM PROGRESSION : Avonex Side Effects Report #5568486-7
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Genotropin Side Effects Report #5514697-6
Consumer or non-health professional from GERMANY reported GENOTROPIN problem on Nov 06, 2007. Male patient, weighting 154.3 lb, was diagnosed with hypopituitarism and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pituitary tumour benign, . GENOTROPIN dosage: DAILY DOSE:1.5MG-FREQ:DAILY. During the same period patient was treated with TESTOSTERONE. Patient recovered.
NEOPLASM PROGRESSION : Gliadel Side Effects Report #5526709-4
GLIADEL problem was reported by a Health Professional from UNITED STATES on Feb 09, 2007. Female patient was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, postoperative wound infection, . GLIADEL dosage: unknown. Patient was hospitalized. Patient died on 11/23/2006.
NEOPLASM PROGRESSION : Velcade Side Effects Report #5533893-5
Physician from UNITED KINGDOM reported VELCADE problem on Nov 16, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . VELCADE dosage: unknown. Patient died on 01/07/2007.
NEOPLASM PROGRESSION : Prialt Side Effects Report #5483216-5
PRIALT problem was reported by a Physician from AUSTRIA on Sept 27, 2007. Male patient, 54 years of age, weighting 147.7 lb, was diagnosed with cancer pain and was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.
NEOPLASM PROGRESSION : Prialt Side Effects Report #5491434-5
Physician from UNITED KINGDOM reported PRIALT problem on Oct 03, 2007. Male patient, 54 years of age, weighting 147.7 lb, was diagnosed with cancer pain and was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.
NEOPLASM PROGRESSION : Avastin Side Effects Report #5499996-9
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, small intestinal obstruction, . AVASTIN dosage: unknown. During the same period patient was treated with FOLINIC ACID, FLUOROURACIL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Isotretinoin Side Effects Report #5500282-9
Pharmacist from UNITED STATES reported ISOTRETINOIN problem on Oct 16, 2007. Female patient was diagnosed with neuroblastoma and was treated with ISOTRETINOIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, off label use, . ISOTRETINOIN dosage: 40 MG, BID. Patient died on 01/13/2007.
NEOPLASM PROGRESSION : Claravis Side Effects Report #5500428-2
CLARAVIS problem was reported by a Physician from UNITED STATES on Oct 17, 2007. Male patient was diagnosed with pinealoblastoma and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pinealoblastoma, . CLARAVIS dosage: unknown. During the same period patient was treated with PEPCID, TYLENOL, DEXAMETHASONE, FOLIC ACID, ZOLOFT. Patient died.
NEOPLASM PROGRESSION : Zometa Side Effects Report #5469653-3
Health Professional from UNITED STATES reported ZOMETA problem on Sept 26, 2007. Male patient, 57 years of age, weighting 220.0 lb, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . ZOMETA dosage: 4MG Q 90 DAYS IV. During the same period patient was treated with LOTREL, MINOCYCLINE, LEXAPRO, ZOCOR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Bevacizumab Side Effects Report #5394701-9
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . BEVACIZUMAB dosage: 850 MG, Q3W. During the same period patient was treated with ERLOTINIB, METFORMIN, ACETAMINOPHEN, CITALOPRAM. Patient died on 07/04/2007.
NEOPLASM PROGRESSION : Betaseron Side Effects Report #5400801-7
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 16, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, prostate examination abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Bevacizumab Side Effects Report #5394701-9
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . BEVACIZUMAB dosage: 850 MG, Q3W. During the same period patient was treated with ERLOTINIB, METFORMIN, ACETAMINOPHEN, CITALOPRAM. Patient died on 07/04/2007.
NEOPLASM PROGRESSION : Betaseron Side Effects Report #5400801-7
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 16, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, prostate examination abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Zometa Side Effects Report #5677265-1
ZOMETA problem was reported by a Health Professional from UNITED STATES on Mar 21, 2008. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, neoplasm progression, . ZOMETA dosage: 4MG Q 90 DAYS IV. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5618840-X
Physician from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 49 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, neoplasm progression, renal failure acute, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/25/2007.
NEOPLASM PROGRESSION : Avastin Side Effects Report #5625187-4
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Jan 29, 2008. Male patient was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal perforation, neoplasm progression, oedema, . AVASTIN dosage: unknown. During the same period patient was treated with XELODA, OXALIPLATIN. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Velcade Side Effects Report #5632249-4
Physician from JAPAN reported VELCADE problem on Feb 01, 2008. Male patient, 61 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/31/2008.
NEOPLASM PROGRESSION : Cabergoline Side Effects Report #5633346-X
CABERGOLINE problem was reported by a Physician from UNITED STATES on Feb 09, 2008. Female patient was diagnosed with prolactinoma and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, neoplasm progression, . CABERGOLINE dosage: unknown. During the same period patient was treated with DOSTINEX. Patient recovered.
NEOPLASM PROGRESSION : Vectibix Side Effects Report #5584600-1
Health Professional from UNITED STATES reported VECTIBIX problem on Dec 26, 2007. Male patient was diagnosed with colorectal cancer and was treated with VECTIBIX. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, neoplasm progression, . VECTIBIX dosage: unknown. Patient recovered.
NEOPLASM PROGRESSION : Seroquel Side Effects Report #5589996-2
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2008. Female patient, 26 years of age, was diagnosed with convulsion and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . SEROQUEL dosage: unknown. During the same period patient was treated with TOPAMAX, CYMBALTA. Patient died on 09/13/2007.
NEOPLASM PROGRESSION : Gemcitabine Side Effects Report #5591371-1
Health Professional from UNITED STATES reported GEMCITABINE problem on Jan 11, 2008. Female patient, 54 years of age, weighting 175.5 lb, was diagnosed with lung neoplasm malignant and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: metastases to spine, neoplasm progression, . GEMCITABINE dosage: 1520 MG DAY 1 AND 8 IV. During the same period patient was treated with CAPECITABINE, OXYCODONE, OXYCONTIN. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Rapamune Side Effects Report #5593519-1
RAPAMUNE problem was reported by a Physician from GERMANY on Jan 04, 2008. Female patient was diagnosed with prophylaxis against transplant rejection and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer recurrent, neoplasm progression, . RAPAMUNE dosage: unknown. Patient recovered.
NEOPLASM PROGRESSION : Genotropin Side Effects Report #5596847-9
Consumer or non-health professional from UNITED KINGDOM reported GENOTROPIN problem on Jan 11, 2008. Male patient, 45 years of age, weighting 202.8 lb, was diagnosed with hypopituitarism and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: craniopharyngioma, neoplasm progression, . GENOTROPIN dosage: unknown. During the same period patient was treated with TESTOSTERONE, DDAVP. Patient recovered.
NEOPLASM PROGRESSION : Revlimid Side Effects Report #5645782-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone pain, neoplasm progression, tumour marker increased, white blood cell count decreased, . REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL; 10 MG, DAILY X 21 DAYS, ORAL 5MG-10MG, DAILY, ORAL. Patient recovered.
NEOPLASM PROGRESSION : Thyrogen Side Effects Report #5549672-9
Physician from UNITED STATES reported THYROGEN problem on Nov 20, 2007. Female patient, 82 years of age, was diagnosed with metastasis and was treated with THYROGEN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, neoplasm progression, respiratory failure, thyroid cancer, . THYROGEN dosage: MG ONCE IM. Patient died on 01/01/2003.
NEOPLASM PROGRESSION : Prinivil Side Effects Report #5566702-9
PRINIVIL problem was reported by a Physician from GERMANY on Dec 12, 2007. Female patient, 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with PRINIVIL. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, neoplasm progression, psychomotor hyperactivity, sleep disorder, . PRINIVIL dosage: unknown. During the same period patient was treated with LYSODREN. Patient was hospitalized. Patient died.
NEOPLASM PROGRESSION : Temodal Side Effects Report #5567364-7
Physician from JAPAN reported TEMODAL problem on Dec 07, 2007. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with disease recurrence, glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, neoplasm progression, pneumonia aspiration, sepsis, vomiting, white blood cell count decreased, . TEMODAL dosage: 15 MG/M2; QD; PO; 100 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; PO. During the same period patient was treated with EXCEGRAN. Patient recovered.
NEOPLASM PROGRESSION : Prinivil Side Effects Report #5570970-7
PRINIVIL problem was reported by a Physician from UNITED STATES on Dec 12, 2007. Female patient, 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with PRINIVIL. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, neoplasm progression, psychomotor hyperactivity, sleep disorder, . PRINIVIL dosage: unknown. During the same period patient was treated with LYSODREN. Patient was hospitalized. Patient died.
NEOPLASM PROGRESSION : Cabergoline Side Effects Report #5573839-7
Physician from UNITED STATES reported CABERGOLINE problem on Dec 14, 2007. Female patient was diagnosed with prolactinoma and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, neoplasm progression, . CABERGOLINE dosage: unknown. During the same period patient was treated with DOSTINEX. Patient recovered.
NEOPLASM PROGRESSION : Claravis Side Effects Report #5575526-8
CLARAVIS problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Male patient, child 2 years of age, was diagnosed with brain neoplasm malignant, off label use and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, neoplasm progression, refusal of treatment by relative, . CLARAVIS dosage: 20 MG, BID, ORAL. During the same period patient was treated with TEMODAR. Patient recovered.
NEOPLASM PROGRESSION : Thyrogen Side Effects Report #5510793-8
Physician from UNITED STATES reported THYROGEN problem on Oct 31, 2007. Female patient, 82 years of age, was diagnosed with high frequency ablation and was treated with THYROGEN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, neoplasm progression, . THYROGEN dosage: MG ONCE IM. Patient died on 01/01/2003.
NEOPLASM PROGRESSION : Temodal Side Effects Report #5527909-X
TEMODAL problem was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 24 years of age, weighting 94.80 lb, was diagnosed with medulloblastoma recurrent and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, neoplasm progression, pneumonia, respiratory disorder, staphylococcal infection, . TEMODAL dosage: PO; 200 MG/M2;QD; PO. During the same period patient was treated with RANIMUSTINE, METHOTREXATE, IFOSFAMIDE, LOXONIN, PREDNISOLONE. Patient was hospitalized. Patient died on 02/21/2007.
NEOPLASM PROGRESSION : Prialt Side Effects Report #5480208-7
Physician from UNITED KINGDOM reported PRIALT problem on Sept 19, 2007. Male patient, 54 years of age, weighting 147.7 lb, was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: angiosarcoma, neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.
NEOPLASM PROGRESSION : Flagyl Side Effects Report #5499210-4
FLAGYL problem was reported by a Consumer or non-health professional from on Oct 15, 2007. Female patient, 86 years of age, was diagnosed with atrial fibrillation and was treated with FLAGYL. After drug was administered, patient experienced the following problems/side effects: haematuria, neoplasm progression, . FLAGYL dosage: unknown. During the same period patient was treated with CORDARONE, COUMADIN, INNOHEP, LEVOTHYROX, ROCEPHIN. Patient was hospitalized. Patient died on 03/24/2007.
NEOPLASM PROGRESSION : Temodal Side Effects Report #5500165-4
Physician from GERMANY reported TEMODAL problem on Oct 18, 2007. Female patient was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: brain oedema, neoplasm progression, . TEMODAL dosage: unknown. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Erlotinib Side Effects Report #5407462-1
ERLOTINIB problem was reported by a Physician from SWITZERLAND on July 19, 2007. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, refusal of treatment by patient, . ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, METFORMIN, ACETAMINOPHEN, CITALOPRAM HYDROBROMIDE. Patient died on 07/04/2007.
NEOPLASM PROGRESSION : Erlotinib Side Effects Report #5413053-9
Physician from SWITZERLAND reported ERLOTINIB problem on July 25, 2007. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, neoplasm progression, non-small cell lung cancer stage iv, pericardial effusion malignant, pulmonary congestion, syncope, tachycardia, . ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Alimta Side Effects Report #5421919-9
ALIMTA problem was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Female patient, 51 years of age, weighting 88.00 lb, was diagnosed with neoplasm malignant and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: dysphagia, neoplasm progression, throat tightness, . ALIMTA dosage: unknown. During the same period patient was treated with AVASTIN, FOLIC ACID. Patient was hospitalized. Patient recovered.
NEOPLASM PROGRESSION : Doxil Side Effects Report #5380852-1
Consumer or non-health professional from UNITED STATES reported DOXIL problem on June 27, 2007. Female patient was diagnosed with ovarian cancer and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: blister, neoplasm progression, oedema peripheral, . DOXIL dosage: unknown. Patient recovered.